- Home
- SLG vs ITGR Comparison
SLG vs ITGR Comparison
Compare SLG & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLG | ITGR |
|---|---|---|
| Founded | 1980 | 1970 |
| Country | United States | United States |
| Employees | 1289 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.0B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | SLG | ITGR |
|---|---|---|
| Price | $43.89 | $89.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 7 |
| Target Price | $50.68 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 1.2M | 376.7K |
| Earning Date | 04-15-2026 | 04-30-2026 |
| Dividend Yield | ★ 7.14% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.89 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | N/A | $1.69 |
| Revenue Next Year | N/A | $6.53 |
| P/E Ratio | ★ N/A | $31.27 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $34.77 | $62.00 |
| 52 Week High | $66.91 | $127.56 |
Technical Indicators
Market Signals| Indicator | SLG | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 68.00 | 57.95 |
| Support Level | $43.21 | $82.58 |
| Resistance Level | $47.34 | $110.93 |
| Average True Range (ATR) | 1.67 | 2.05 |
| MACD | 0.81 | 0.33 |
| Stochastic Oscillator | 99.25 | 74.21 |
Price Performance
Historical ComparisonAbout SLG SL Green Realty Corp
SL Green Realty is one of the largest Manhattan property owners and landlords, with interest in around 32 million square feet of wholly owned and joint-venture office space. The company has additional property exposure through its limited portfolio of well-located retail space. It operates as a real estate investment trust.
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.